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ABSTRACT 
A lactate/O2 enzymatic biofuel cell (EBFC) was prepared as a potential power source for 
wearable micro-electronic devices. Mechanically stable and flexible nanoporous gold 
(NPG) electrodes were prepared using an electrochemical dealloying method consisting 
of a pre-anodization process and a subsequent electrochemical cleaning step. Bioanodes 20 
were prepared by the electrodeposition of an Os polymer and Pediococcus sp. lactate 
oxidase onto the electrode. The electrocatalytic response to lactate could be tuned by 
adjusting the deposition time. Bilirubin oxidase from Myrothecium verrucaria was 
covalently attached to a diazonium modified NPG surface. A flexible EBFC was  
prepared by placing the electrodes between two commercially available contact lenses to 25 
avoid direct contact with the eye. When tested in air-equilibrated artificial tear solutions 
(3 mM lactate), a maximum power density of 1.7±0.1 μW cm-2 and an open-circuit 
voltage of 380±28 mV was obtained, values slightly lower than in phosphate buffer 
solution (2.4±0.2 μW cm-2 and 455±21 mV, respectively). The decrease was mainly 
attributed to interference from ascorbate. After 5.5 h of  operation, the EBFC retained  30 
20% of the initial power output. 
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1. INTRODUCTION 5 
Enzymatic biofuel cells (EBFCs) have been extensively investigated 1-3, since the first 
prototype consisting of a glucose oxidase (GOx) modified anode and a Pt cathode was 
introduced by Yahiro et al. in 1964 4. EBFCs enjoy advantages such as ease of 
miniaturisation and the ability to operate at physiological conditions. EBFCs that mimic 
metabolic pathways (most interestingly, glucose oxidation) in the body have been 10 
envisioned as autonomous power suppliers for implantable medical devices since the 
1970s 5. Significant efforts have been directed towards designing implantable EBFCs, 
with EBFCs examined in vivo in rats 6-9, snails 10, lobsters 11, etc. Recently, EBFCs have 
been tested ex vivo in human blood 12-13. However, practical applications of EBFCs 
operating in the human body have been hindered by i) the relatively large size of the 15 
devices 9, ii) the limited lifetime due to the deactivation and/or leakage of enzyme 13 and 
iii) low power density due to inefficient rates of electron transfer between the enzymes 
and the electrode surface, accompanied by the limited mass-transport of substrates. The 
supply of O2 in particular is a significant constraint for in vivo operation and thus oxygen-
reducing biocathodes are a significant limiting factor 3, 12. 20 
 
Non-invasive EBFCs utilising fuels in saliva 14-15, sweat 16, tear 17, etc., offer an 
alternative that can circumvent issues caused by implantation. This type of EBFC avoids 
direct contact with the immune system and removes the necessity of a surgical procedure. 
Such devices can be easily discarded and replaced and can be used to activate wearable 25 
medical devices for continuous health monitoring and applications in sports science 18. In 
comparison to implantable glucose/O2 EBFCs that utilise glucose and O2 in blood, 
lactate/O2 biofuel cells have more potential for use with wearable electronics due to the 
higher concentration of lactate in tears and in sweat. For example, the normal 
concentrations of glucose and lactate in  human blood range from 3.3-6.5 mM and 0.5-0.8 30 
mM, respectively, in comparison to 0.1-0.6 mM and 2-5 mM, respectively in human tears 
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19. Lactate is an important biomarker of metabolic efficiency during physical exercise. A 
correlation between the concentration of lactate in sweat and in blood has been described 
by Sakharov et al., indicating that sweat lactate levels can be measured to evaluate 
changes in blood lactate concentrations 20. Self-powered lactate biosensors based on the 
construction of lactate EBFCs, have been demonstrated showing a linear increase in 5 
power density for lactate concentrations between 0 and 5 mM 21. 
A promising type of wearable device is the temporary tattoo EBFC 22. Wang et al. 
successfully fabricated an EBFC that can be attached on the skin to harvest energy from 
lactate present in human sweat during physical exercise 16. The transferrable tattoo based 
EBFC employed a mediated lactate oxidase (LOx) bioanode and a platinum black 10 
cathode. Another interesting type of wearable EBFC is that incorporated on a contact lens 
23. Basal tears containing a range of species such as lactate, glucose, ascorbate, saturated 
air, etc., keep the cornea moist, making the preparation of continuous and self-sustained 
EBFCs possible during physical movement and under quiescent conditions. Contact 
lenses floating on the cornea for myopia correction are commercially available. Recently, 15 
new roles for such systems, including sensors 24-27, digital displays 28 and drug release 29 
have been described. Falk et al. first reported experimental proof of a 3D nanostructured 
gold wire supported glucose/O2 EBFC that could be used on contact lenses 30. Follow-up 
work from the same group described a hybrid EBFC relying on an abiotic anode to 
oxidise ascorbate and a bilirubin oxidase (BOx) based biocathode to reduce oxygen in 20 
real human tears 17. Minteer et al. described the preparation of a buckypaper supported 
EBFC assembled with a lactate dehydrogenase (LDH) bioanode and a BOx biocathode 
that was deposited on a curved elastomeric substrate 31, registering a maximum power 
density of 2.4 ± 0.9 µW cm-2 32. 
 25 
Electrode materials for tear based EBFCs should (i) be flexible enough to be seamlessly 
attached onto the eyeball, (ii) exhibit high surface areas to ensure high enzyme loadings 
for larger current densities and (iii) be biocompatible for use on the eye 23. Dealloyed 
nanoporous gold (NPG) 33 possesses a three-dimensional porous structure fabricated via 
the etching of gold alloys and is a promising substrate for EBFCs 34-37. The pore sizes can 30 
be finely tuned to accommodate enzymes in a manner that optimises the electrocatalytic 
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response 36, 38-39. Thin (100 nm) NPG leaves have been used as the electrode material of 
flexible supercapacitors 40. However, Au-Ag NPG prepared from these leaves are brittle 
34, while the preparation conditions (concentrated nitric acid) used for chemical etching 
are highly corrosive 37, 41, with concomitant safety and environmental concerns. To 
overcome these issues, we electrochemically dealloyed Au-Ag alloys at neutral pH to 5 
fabricate mechanically robust NPG electrodes. A polyethylene terephthalate (PET) film 
was used to provide a flexible substrate. LOx and BOx were immobilised onto the 
electrode with the assistance of [Os(2,2′-bipyridine)2(polyvinylimidazole)10Cl]+/2+ 
(Os(bpy)2PVI) 35 and diazonium grafting 36, separately, for the bioanode and biocathode. 
The EBFC was enclosed between two commercially available contact lenses (Scheme 1) 10 
to avoid direct contact with the eye 31-32. Hydrophilic silicon-hydrogel contact lenses 
contain micro-channels to enable the transport of solutions and oxygen to the EBFC 42. 
The performance of the EBFC was examined in solutions containing phosphate buffer 
solution (PBS) and artificial tears, exhibiting a maximum power density of 2.4±0.2 and 
1.7±0.1 μW cm-2, respectively.  15 
 
Scheme 1. Schematic diagram of the assembly of the modified contact lens (A) and the 
configuration of the EBFC (B). 
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2. EXPERIMENTAL SECTION 
2.1. Materials and apparatus 
Sodium phosphate (monobasic dehydrate ≥99% and dibasic ≥99%), sodium fluoride 
(NaF, 99.99%), hydrochloric acid (HCl, 37%), sulfuric acid (H2SO4, 95-98%), D-(+)-
glucose (99.5%), sodium nitrite (NaNO2, ≥99.999%), 6-amino-2-naphthoic acid (NA, 25 
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90%), 3-mercaptopropionic acid (MPA, ≥99%), L-ascorbic acid (≥99%), urea (≥99.5%), 
sodium L-lactate (≥99%), N-cyclohexyl-N’-(2-morpholinoethyl) carbodiimide metho-p-
toluenesulfonate (CMC, ≥99%), lysozyme human (EC 3.2.1.17), bovine serum albumin 
(BSA), mucin from porcine stomach and Pediococcus sp. LOx (EC 1.13.12.4, ≥20 U mg-
1) were purchased from Sigma-Aldrich Ireland, Ltd. Anhydrous acetonitrile (>99.8%) 5 
was obtained from Fisher Scientific, Ireland. Myrothecium verrucaria BOx (EC 1.3.3.5, 
2.63 U mg-1) was obtained as a gift from Amano Enzyme Inc., Japan. Os(bpy)2PVI was 
synthesised using an established procedure 43-44. Silicon-hydrogel contact lenses (-0.5 and 
-9.0 diopter) were obtained locally.  Deionised water (18.2 MΩ cm, Elga Purelab Ultra, 
UK) was used for all preparations. 10 
 
Morphology studies were performed with a Hitachi SU-70 scanning electron microscope 
(SEM, 10 kV), equipped with an energy dispersive X-ray spectroscopy (EDX) for 
residual Ag determination. ImageJ software (National Institutes of Health, Bethesda, 
Maryland) 45 was used to measure the average pore size and crack width of NPG by 15 
analysing at least 30 measurement points.  
 
2.2. Electrochemical dealloying  
Magnetron sputtered Ag/Au alloy was prepared in an ultra-high vacuum chamber at room 
temperature according to a previous report 38. Briefly, Ar plasma treated microscope glass 20 
slides or 100 µm thin PET substrates were coated with a 10 nm Ti adhesive layer, ca. 35 
nm Au protective layer and 100 nm Ag70/Au30 (atomic %) alloy layer, subsequently. The 
glass supported alloy sheets were cut using a circular saw and painted with dielectric 
paste (Gwent Group, UK) to define an electroactive surface area of ca. 0.3 cm2. 
Cleanroom tape composed of a polyamide film (VWR, Ireland) was used to define the 25 
electrode area (0.35*0.35 cm2) of the PET supported alloy sheets. 
 
To prepare NPG, the alloy was anodized at +1.05 and +1.5 V vs. SCE in 0.5 M NaF at 
room temperature (20±2 °C) for 10 min and subsequently cleaned by scanning the 
potential from -0.2 to 1.65 V in 1 M H2SO4 at a scan rate of 100 mV s-1 for a range of 30 
potential cycles (1 to 15). The electrochemically addressable surface area (Areal) of NPG 
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and the roughness factor (Rf), i.e. the ratio of Areal to the geometric area (Ageo), was 
obtained by cyclic voltammetry using a value of 390 μC cm-2 for the reduction of a single 
layer of gold oxide 46. 
 
2.3. Enzyme immobilisation  5 
NPG based bioanodes were prepared by electrodeposition at -1.1 V for different durations 
(60-600 s) in 0.1 M pH 7.0 PBS containing 1 mg ml-1 Os(bpy)2PVI and 1 mg ml-1 of 
LOx. The surface coverage (nmol cm-2) of Os polymer on the electrode was calculated 
according to the equation: 
Surface coverage =
𝑄
𝑛𝐹𝐴
 (1) 10 
where Q (nC) is the charge regarding to the oxidation/reduction of Os polymer 
determined based on the cyclic voltammograms (CVs) in a blank PBS, n is the number of 
electrons involved, F is the Faraday constant (96485 C mol-1) and A (cm-2) is the 
geometric area of the electrode. 
 15 
BOx was covalently attached to NPG via a 2-carboxy-6-naphtoyl diazonium salt (NA-
DS) modification layer, which was synthesised according to a previous report 36. Briefly, 
a fresh NA-DS solution was obtained by dropwise addition of 2 mL of 2 M HCl 
containing 2 mM NaNO2 into a 2 mL solution of 20 mM NA in acetonitrile, in an ice 
bath. Electrografting was achieved by electrochemically reducing NA-DS at the electrode 20 
surface with a single potential scan over the potential range 0.6 to -0.6 V at a scan rate of 
200 mV s-1 (Figure S1). The modified electrodes were immersed into a 1 mM MPA 
aqueous solution overnight to block any unmodified gold surface, followed by carefully 
rinsing with deionised water and dried in vacuum. A 20 μL aliquot of BOx (0.5 mg mL-1) 
was drop cast onto the surface of the electrode, incubated in a vacuum chamber for 5 min 25 
and then transferred to a fridge at 4 °C for 1 h. The modified electrodes were then 
immersed in a solution of CMC (5 mM) at 4 °C for 2 h to crosslink the enzyme 
molecules. 
 
2.4. Electrochemical measurements 30 
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Electrochemical experiments were carried out with a CHI802 potentiostat (CH 
Instruments, Austin, Texas) in a three-electrode electrochemical cell consisting of the Au 
alloy or NPG based working electrode, a platinum counter electrode and saturated 
calomel electrode (SCE) as the reference electrode. 
 5 
The assembled EBFC was tested in a two-electrode system by using a LOx based 
bioanode as the working electrode and a BOx based biocathode as the combined 
counter/reference electrode, recording the current in the potential range between the open 
circuit voltage of the EBFC and 0 V at 1 mV s-1. The power density curve was calculated 
using the geometric area of the limiting electrode. All experiments were performed at 10 
room temperature (20±2 °C) unless stated otherwise.  
 
To test the contact lens supported EBFC, a contact lens (diopter -9.0) was first mounted 
onto the polycarbonate packing material used to package the contact lens. The material 
had the same curved surface shape of the lens. It was first  treated with O2 plasma (30 s, 15 
Solarus 950 Advanced Plasma System, Gatan, USA) and the NPG based EBFC 
electrodes were then placed on the lens followed by a thinner contact lens (diopter -0.5) 
(Scheme 1). Artificial tear solutions 32 (a mixture of 50 µM glucose, 3 mM lactate, 180 
µM ascorbate, 5.4 mM urea, 2.47 mg mL-1 lysozyme, 0.2 mg mL-1 BSA, and 0.15 mg 
mL-1 mucin in 0.1 M pH 7.0 PBS) were maintained at 35 °C and continuously dropped 20 
onto the contact lenses with a peristaltic pump (P720, Instech, USA). 
 
3. RESULTS AND DISCUSSION 
3.1. Electrochemical dealloying 
Dealloying of gold alloys is normally performed in concentrated nitric acid (ca. 15.7 M) 25 
at temperatures of 30 °C or higher 38, 47-49. In contrast, there has only been a few reports 
describing the dealloying of gold alloys at neutral pH. Such methods are based on the 
electrochemical oxidation of the less noble element and subsequent removal of the 
oxidised product 50-51. Expensive salt solutions (such as AgNO3) were used to dealloy 
Ag65/Au35 (atomic %) at an applied potential between 1.4 and 2 V vs. NHE 50. Al/Au 30 
alloys were electrochemically dealloyed in solutions of NaCl 51. However, in dealloying 
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Ag/Au alloys, the use of NaCl as an electrolyte may result in the precipitation of 
insoluble AgCl 52. Therefore, NaF was selected as a low cost alternative electrolyte for 
electrochemical dealloying.  
Linear sweep voltammogram (LSV) of Ag70/Au30 alloy (sputtered on glass) in 0.5 M NaF 
(Figure 1A) displayed peaks corresponding to the oxidation of Ag (0.77 to 1.22 V vs. 5 
SCE and the evolution of oxygen (onset potential of 1.25 V vs. SCE), consistent with 
data from the Pourbaix diagram for Ag 53. To illustrate the effect of oxidation potential, 
two representative potentials, 1.05 and 1.5 V in the region of Ag oxidation and OER 
respectively, were chosen (Figure 1A). After 10 min at room temperature, both potentials 
led to NPG with similar morphology (Figure 2B and Figure S2A) showing pinholes with 10 
very small average pore sizes (8.2±2  and ~5 nm at 1.05 and 1.5 V, respectively, Figure 3, 
Table S1 and S2) and wide cracks due to stress release on volume contraction during the 
dealloying process 49 (20±4.2 and 16.8±4.1 nm at 1.05 and 1.5 V, respectively Figure 3, 
Table S1 and S2). EDX analysis confirmed that a significant amount of Ag (12.2±0.3% at 
1.05 V and 13.6±0.4% at 1.5V, Figure 3, Table S1 and S2) remained, due to the presence 15 
of residual silver oxide passivating further silver dissolution 50. This was consistent with 
the observation that longer anodisation times (>10 min) resulted in no significant changes 
in terms of average pore size and Ag content. To obtain NPG electrodes with suitable 
pore sizes for enzyme immobilisation, the residual oxide was removed by cycling the 
applied potential in 1 M H2SO4 50, which is an established protocol to create clean gold 20 
electrode surfaces 30, 41, 54. As  potential cycling continued (Figure 1B), the small peaks 
corresponding to removal of Ag at ca. +0.2 V started to disappear after the second 
potential cycle. Meanwhile, the reduction peak of gold oxide at ca. 0.85 V (Figure 1B) 
decreased due to coarsening of NPG 55 that was associated with an increase in the average 
pore size and a decrease in the specific surface area 41, 48. SEM (Figure 2B, C and D, 25 
Figure S2) and EDX (Figure 3, Table S1 and S2) results reinforced these observations. 
NPG anodised at 1.05 and 1.5 V (Figure 3, Table S1 and S2) both showed decreases in 
the amounts of silver remaining, with increases in pore sizes and decreases in the surface 
roughness. The observed cracks grew in size with continuous potential cycling, until they 
were in the same size range of the pores and no longer distinguishable from them after 30 
the 15th scan 38. The observed pore evolution process during potential scanning is quite 
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similar to that reported on glass supported Ag/Au alloys during etching by concentrated 
nitric acid 38. NPG prepared at potentials of 1.05 and 1.5 V both generated satisfactory 
nanoporous structures in terms of acceptable Rf and pore sizes. For further studies, 1.5 V 
was used as the optimal potential as the resulting pore sizes (20.2±5.1 nm) and large Rf 
values (17.0±0.8) were suitable for enzyme immobilisation. 5 
Figure 1. (A) Linear sweep voltammogram of Ag70/Au30 alloy in 0.5 M NaF. (B) Cyclic 
voltammograms of the as-anodised NPG (1.5 V) in 1 M H2SO4. 
 
Control experiments performed by cycling the potential in H2SO4 without anodisation 
also resulted in the appearance of nanoporous structures (Figure S3 and Table S3). After 10 
two cycles, only 4.7±0.4% Ag remained in the alloy. The electrodes had an average pore 
size of ca. 5 nm and also displayed large cracks (40.3±8.2 nm, Figure S3A, Table S3). In 
contrast, anodisation resulted in enriched Ag content (12.2±0.3% at 1.05 V and 
13.6±0.4% at 1.5V, Figure 3, Table S1 and S2) on the surface and etching of Ag was 
relatively slower as it was impeded by the presence of silver oxide, thus resulting in 15 
smaller crack sizes (20±4.2 nm for 1.05 V and 16.8±4.1 nm for 1.5 V, Figure 3, Table S1 
and S2). Cyclic voltammograms of the electrodes in H2SO4 resulted in the extraction of 
the surface-enriched Ag and re-configuration of surface Au atoms (i.e. surface re-
arrangement) 41, 50, 55. Without anodisation, direct etching in H2SO4 stripped Ag from the 
bulk, immediately leading to rapid volume changes and resulting in large cracks. 20 
Additional potential scans (up to 15 cycles (Figure S3B, Table S3)) resulted in NPG with 
low Rf (4.0±0.2) and expanded crack sizes(44.6±5.7 nm). The obtained microstructure 
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showed unconnected ligaments when scanned to the 30th cycle (Figure S3B). In 
conclusion, potential cycling in H2SO4 without anodisation resulted in NPG with pores 
that were too small for enzymes to enter (2 cycles) or unsatisfactory roughness (15 and 30 
cycles) (Table S3). Thus, it is essential to first anodise the precursor to obtain the optimal 
NPG structure. Figure 2A illustrates a possible mechanism of the two-step 5 
electrochemical dealloying process. Anodisation generates silver oxide passivated NPG 
with pinholes. Subsequent coarsening  of the surface  in H2SO4 removes the residual 
silver oxides and allows re-configuration of the surface gold atoms via repeated electro-
oxidation/reduction.  
 10 
 
Figure 2. (A) Schematic diagram of the electrochemical dealloying process. (B-E) SEM 
images of the porous structure of NPG obtained at different conditions. B: anodisation in 
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0.5 M NaF at 1.5 V vs. SCE for 10 min, anodisation and cycling potential in 1 M H2SO4 
for 1 (C), 2 (D) and 15 (E) potential cycles. 
 
 
 5 
Figure 3. Plots of (A) roughness factor; (B) residual silver content; (C) pore size; (D) 
crack width obtained after potential cycling of as-anodised NPG . 
 
Anodisation followed by cyclic voltammetry in in H2SO4 was performed to dealloy the 
less noble metal Ag from a PET supported Ag70/Au30 alloy. The morphology showed a 10 
continuous porous structure with an average pore size of 20.9±4.2 nm and a crack width 
of 28.4±4.6 nm. The obtained NPG could be bent (Figure 4A) with no obvious structural 
deformation after a 40-degree bend (Figure 4C). Streaks were observed when the 
electrode was bent by 60-degrees (Figure 4D) and the electrode was still conductive due 
to the presence of the underlying Au layer. No delamination occurred even after a 90-15 
degree bend due to the Ti adhesive layer. The sheet resistance (Rs) of the flexible NPG on 
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PET was 3.4± 0.1 Ω sq-1 (Figure S4), with slight increases to 3.5± 0.1 and 3.6 Ω sq-1 after 
bending to 40- and 90-o , respectively. The measured Rs was similar to that of a NPG leaf 
electrode (2.5 Ω sq-1) 56. This type of PET supported NPG is expected to find applications 
such as supercapacitors 40, point-of-care diagnostics 55 and surface enhanced resonance 
Raman scattering (SERRS) sensors 57. Here, we demonstrated the use of such electrodes 5 
for EBFCs. 
 
Figure 4. (A) Digital photo of the PET supported NPG obtained via electrochemical 
dealloying. (B) SEM images of the electrochemically dealloyed NPG, and the 
corresponding microstructure under a 40-degree (C) and 60-degree bend (D). 10 
 
3.2. Characterisation of the bioelectrodes 
FAD-dependent LOx was selected as it can be easily immobilised on an electrode surface 
with redox polymers 21, which simultaneously immobilise the enzyme and shuttle 
electrons from the enzyme to the electrode surface. Os poly(N-vinylimidazole) redox 15 
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polymers have been shown to be promising mediators for use with LOx 58-59. As shown in 
Scheme S1, the oxidation of L-lactate to pyruvate is catalyzed by LOx(FAD), with the 
redox center FAD converted to be the reduced form, FADH2. Oxidation of FADH2 by 
Os(III) in the redox polymer regenerates FAD and produces Os(II) which is subsequently 
re-oxidised to Os(III) at the electrode. Instead of drop-casting which leads to a film with 5 
relatively poor stability,  electrodeposition can be used to co-immobilise enzymes and Os 
polymers containing weakly coordinated chloride ions 60. At a cathodic potential, Os3+ 
was reduced to Os2+, accompanied by exchange of chloride ions with the more strongly 
coordinating pyridine or imidazole groups on the polymer. Such a crosslinking process 
resulted in irreversible polymer precipitation onto the electrode. A negative potential of -10 
1.1 V vs. SCE was used for deposition in the presence of Os(bpy)2PVI and LOx. The 
electrocatalytic responses of the resulting bioelectrodes varied with deposition time 
(Figure 5A). Surface coverages of the Os polymer (Figure 5A, blue curve) increased with 
deposition time. In other words, longer deposition time resulted in an increase in the 
amounts of Os polymer and enzyme that were immobilised 35. The highest response was 15 
obtained with a moderate deposition time of 360 s, reflecting a compromise between the 
loading of the enzyme and mass-transport resistance of lactate through the film 35. As 
shown previously, transmission electron microscopic (TEM) images clearly showed that 
the pores of NPG were blocked by the polymer film when the deposition time was too 
long, leading to a decreased catalytic response 35. A deposition time of 360 s resulted in a 20 
thin film growing along the ligaments without plugging the pores (Figure S5). 
 
Cyclic voltammograms (CVs) of the optimal NPG/Os(bpy)2PVI/LOx bioanode, 
performed in air-equilibrated PBS, exhibited a pair of well-defined redox peaks with an 
integrated anodic-to-cathodic peak area ratio of approximately one and a midpoint redox 25 
potential of 193±1 mV vs. SCE (Figure 5B), attributed to the rapid oxidation/reduction of 
the Os2+/3+. In the presence of 3 mM lactate, a typical sigmoidal catalytic wave appeared, 
with an onset potential of 47±30 mV vs. SCE and a net catalytic response of 62.2±1.9 μA 
cm-2. It’s noteworthy that the reduced form of LOx (FADH2) can also be oxidised by O2 
58, decreasing the current and generating unwanted H2O2 that could deactivate the 30 
enzyme. Additionally, an oxygen depleting bioanode will reduce the substrate 
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concentration for the oxygen-reducing biocathode 61. Thus, oxygen competition was 
studied by comparing the catalytic response in either air-equilibrated or N2-saturated PBS 
containing 3 mM lactate. The ratio of measured current density from air-/N2 solution was 
87.7%, implying a relatively small fraction (12.3%) was assigned to oxygen depletion 
(Figure S6). This is consistent with previous studies that indicated that competition with 5 
oxygen was significant at low lactate concentrations and became negligible at high 
substrate concentrations 58. By varying the lactate concentration, it became clear that 
NPG/Os(bpy)2PVI/LOx displayed a saturated current density when the concentration was 
above 3 mM (Figure 5C). In other words, oxygen competition at the bioanode was not a 
critical concern for the EBFC operation in the presence of 3 mM lactate (Figure 5C). The 10 
electrode had a sensitivity of 19.7±1.4 µA cm-2 mM-1 with a linear range up to 3 mM. 
The apparent Michaelis-Menten constant of the enzyme modified electrode was 1.0±0.4 
mM, which is lower than that obtained from FcMe2-LPEI/LOx modified buckypaper 
(1.6±0.1 mM) 21. NPG/Os(bpy)2PVI/LOx showed considerable stability at +250 mV vs. 
SCE in an air-equilibrated 3 mM lactate PBS solution retaining 63% of its original 15 
response after 2 hours’ continuous operation (Figure S7).  
 
To prepare a biocathode with a high onset potential, BOx was covalently attached to a 
diazonium layer modified NPG (Figure S1) in order to achieve direct electron transfer 
(DET). The porous structure is believed to accommodate BOx in a manner that provides a 20 
favourable orientation for DET 36. The catalytic activity of the BOx-diazonium modified 
NPG was studied by cyclic voltammetry in either N2-bubbled or air-equilibrated PBS at a 
scan rate of 5 mV s-1 (Figure 5D). In the air-equilibrated PBS, a sigmoidal catalytic curve 
was obtained with an onset potential of 503±15 mV vs. SCE and a background-corrected 
current density of 19.5±0.1 μA cm-2. The lower net current density obtained in 25 
comparison to the LOx based bioanode (62.2±1.9 μA cm-2) demonstrated that the output 
of the EBFCs was limited by the biocathode. The same electrode registered a net current 
density of 57.3±1.9 μA cm-2 in an O2-bubbled solution (Figure S8), indicating a substrate 
concentration dependent catalytic behaviour. The obtained current density compares well 
with a previous report 36, where the oxygen reduction response could be enhanced by 30 
increasing the thickness of NPG up to 500 nm. 
 15 
 
 
 
 
Figure 5. (A) Effect of the deposition time for NPG/Os(bpy)2PVI/LOx on the catalytic 5 
response towards 3 mM lactate in air-equilibrated 0.1 M pH 7.0 PBS at 250 mV vs. SCE. 
Blue line indicates the surface coverages of the Os polymer obtained by various 
deposition times. (B) CVs of NPG/Os(bpy)2PVI/LOx (360 s deposition) in air-
equilibrated 0.1 M pH 7.0 PBS at a scan rate of 5 mV s-1. (C) Catalytic response of 
NPG/Os(bpy)2PVI/LOx (360 s deposition) towards various concentrations of lactate in 10 
air-equilibrated 0.1 M pH 7.0 PBS at 250 mV vs. SCE. (D) CVs of the BOx modified 
electrode in 0.1 M pH 7.0 PBS at a scan rate of 5 mV s-1. 
 
3.3. Performance of EBFC  
 16 
The performance of the assembled EBFC was tested in air-equilibrated PBS and artificial 
tear solution containing 3 mM lactate, respectively. The maximum power density 
achieved was 2.4±0.2 μW cm-2 at ca. 237 mV and a maximum short-circuit current 
density of 15.1±3.0 μW cm-2 in a PBS solution (Figure 6C). The obtained open-circuit 
voltage (OCV) was 455±21 mV in PBS, which is consistent with the difference in the 5 
onset potentials for lactate oxidation and oxygen reduction occurring at the bioanode and 
biocathode, respectively. However, the maximum power density and current density 
decreased to 1.7±0.1 μW cm-2 and 11.6±1.5 μA cm-2 when tested in the artificial tear 
solution (Figure 6C). This likely arose from the interference of species such as ascorbate 
and the increased solution viscosity leading to mass transport resistance together with 10 
biofouling on the electrode surface caused by proteins. The anti-biofouling effect of NPG 
has been described in previous reports 62. Significant resistances to fouling caused by 
BSA and fibrinogen were observed, due to the nanoporous structure preventing entry of 
large proteins into the nanoporous network.  
 15 
The decrease in performance was mainly attributed to interference by ascorbate as it can 
be easily oxidised on the nanostructured gold electrode 17, 30. The oxidation of ascorbate 
should be taken into account as it greatly perturbs the biocathode performance, although 
it improves the current observed at the bioanode 31. Detailed investigation of ascorbate 
interference was performed on both the anode and cathode in air-equilibrated PBS 20 
solutions (Figure 7). Bare NPG displayed a faradaic response in 0.18 mM ascorbate with 
a current density of 7.86 μA cm-2 at 174 mV vs. SCE (inset of Figure 7A). The catalytic 
response decreased to 3.15 μA cm-2 on NPG/Os(bpy)2PVI/LOx (Figure 7A), 5% of the 
catalytic current of 62.2±2.0 μA cm-2 to 3 mM lactate. This implies that the Os polymer 
did not act as a mediator for the oxidation of ascorbate and the coating layer restricted the 25 
interference of ascorbate to some extent. Figure 7B shows the effect of ascorbate upon 
the BOx cathode. A decrease of current density by 36% and a shift of the onset potential 
by 90±5mV, consistent with a decrease in OCV from 455±21 to 380±28 mV, were 
observed. Thus, we can conclude that ascorbate does not change the bioanode response 
greatly, but diminishes the biocathode performance in terms of onset potential and current 30 
response. Table 1 compares the performance of the proposed EBFC with previously 
 17 
reported tear based EBFCs. The maximum power density obtained was of the same order 
of magnitude as other lactate/O2 EBFCs 31-32. The maximum power density is ca. two 
times higher than that of a glucose/O2 EBFC due to the low glucose concentration in tear 
fluid 30. While the OCV was ca. 100 mV less than that of a DET based glucose/O2 EBFC 
30, and similar to the values reported for lactate/O2 EBFCs 31-32. The theoretical OCV for 5 
a lactate/O2 EBFC is 1.0 V 23, indicating that a higher OCV is possible. A mediator with a 
lower redox potential (that is still greater than that of FAD (ca. -0.43 V vs. SCE) 63) could 
be used to prepare a LOx modified bioanode with a low onset potential. As described 
earlier, interference from ascorbate results in a decrease of the onset potential. 
Suppression of ascorbate interference, e.g. using a coating of Nafion 64, would also 10 
improve the OCV. 
Figure 6. Photograph of the contact lens encapsulated EBFC (A) and testing setup (B). 
(C) Polarisation and power curves for the EBFC consisting of NPG/Os(bpy)2PVI/LOx 
bioanode and NPG-BOD biocathode. (D) Operational stability of the EBFC at 150 mV in 
artificial tears. 15 
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A stable response  is a prerequisite for an applicable EBFC. The operational stability of 
the EBFC was examined by placing the NPG electrodes between two contact lenses 
(Scheme 1 and Figure 6B) with drop-by-drop supply of artificial tears containing 3 mM 
lactate, etc. The EBFC survived over a period of 5.5 h working at 150 mV (Figure 6D). 
The power density observed decreased significantly by more than 50% during the initial 1 5 
hour period. The EBFC retained ca. 20% of the original output after 5.5 h. The stability 
decay was mainly due to the deterioration of the response of the BOx based biocathode 
35, as the response of the Os polymer modified bioanode was robust (Figure S5). This 
stability is acceptable for use in one-day disposable lenses. 
 10 
Table 1. List of properties of tear based EBFCs. 
Anode Cathode OCV (mV) 
Pmax 
(µWcm-2) 
Stability Ref. 
AuNPs/CtCDH 
0.05 mM glucose 
AuNPs/BOx 
Air-saturated 
570 1 
More than 20 h operational half-
life in human tears 
30 
AuNPs/TTF-TCNQ 
0.665 mM ascorbate 
AuNPs/BOx 
Air-saturated 
540 3.1 
77% loss for the first 1 hour in 
human lachrymal tears 
17 
BP/poly-
MG/LDH/NAD+ 
3 mM lactate 
An-pyr-
MWCNT/TBAB-
modified 
Nafion/BOx 
Solution: n/a 
410±60 8.01±1.4 
80% loss for 4 hours in artificial 
tear 
31 
LOx/FcMe2-LPEI 
3 mM lactate 
An-pyr-
MWCNT/TBAB-
modified 
Nafion/BOx 
Air-saturated 
440 ± 80 2.4 ± 0.9 n/a 32 
NPG/Os(bpy)2PVI/LOx 
3 mM lactate 
NPG-diazonium-
BOx 
Air-equilibrated 
PBS: 455±21 
Artificial 
tear: 380±28 
PBS: 2.4±0.2 
Artificial tear: 
1.7±0.1 
~20% of initial power retained 
after 5.5 h operation in artificial 
tear 
This 
work 
Note: CtCDH: Corynascus thermophilus cellobiose dehydrogenase; AuNPs: gold nanoparticles; TTF-
TCNQ: tetrathiafulvalene-tetracyanoquinodimethane; BP: buckypaper; poly-MG: polymerized 
methylene green; FcMe2-LPEI: dimethylferrocene-modified linear polyethyleneimine; An-pyr: 
anthracene-pyrene; MWCNT: multi-walled carbon nanotube; TBAB: tetrabutylammonium bromide.  15 
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Figure 7. Effects of the presence of 0.18 mM ascorbate towards bioanode (A) and 
biocathode (B). Inset of (A) shows the response on a bare NPG. 
 
4. CONCLUSIONS 5 
Flexible NPG were successfully fabricated using an electrochemical dealloying method. 
The electrodes were modified with lactate oxidase and bilirubin oxidase for use as a 
lactate/O2 biofuel cell, which was subsequently tested in a solution of artificial tears. The 
flexible EBFC holds potential as an autonomous power supply for  wearable electronic 
devices. Ascorbate interference, especially at the biocathode, were responsible for the 10 
decrease in performance in tears in comparison to the performance in phosphate buffer 
solution. A coating film on the biocathode may alleviate such interference effects. The 
response of the assembled EBFC was limited by current density and operational stability 
of the biocathode. Improvements in the observed current density of the biocathode will 
enable the development of a self-powered lactate biosensor on a contact lens, where the 15 
power density of the EBFC could be correlated with the concentration of lactate. 
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